Enrolling by invitationNCT07521384

Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy

Studying Dementia pugilistica

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Healing Hope International
Principal Investigator
Dr. Glen Cronett, PhD/MD
Kurve Therapeutics
Enrollment
36 target
Eligibility
4-80 years · All sexes
Timeline
2026 – 2029

Study locations (1)

Collaborators

Kurve Technology Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07521384 on ClinicalTrials.gov

Other trials for Dementia pugilistica

Additional recruiting or active studies for the same condition.

See all trials for Dementia pugilistica →

← Back to all trials